MAX and small cell lung carcinoma: Intriguingly, it has been recently reported that MAX-inactivating alterations occur in ~6% of SCLCs in a mutually exclusive manner to amplification of MYC family genes, highlighting the relevance of MYC pathway in SCLC progression [17].